Enanta Pharmaceuticals
ENTA
#7360
Rank
NZ$0.77 B
Marketcap
NZ$26.73
Share price
5.92%
Change (1 day)
156.67%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$0.37 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total liabilities are NZ$0.37 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enanta Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30NZ$0.39 B-4.64%
2023-09-30NZ$0.40 B326.94%
2022-09-30NZ$95.93 M68.09%
2021-09-30NZ$57.07 M23.72%
2020-09-30NZ$46.13 M5.68%
2019-09-30NZ$43.65 M40.71%
2018-09-30NZ$31.02 M-10.62%
2017-09-30NZ$34.7 M122.19%
2016-09-30NZ$15.62 M1.26%
2015-09-30NZ$15.42 M78.17%
2014-09-30NZ$8.65 M10.41%
2013-09-30NZ$7.84 M-21.15%
2012-09-30NZ$9.94 M84.28%
2011-09-30NZ$5.39 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AbbVie
ABBV
NZ$237.05 B 63,088.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$197.18 B 52,460.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$13.10 B 3,392.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$134.83 B 35,841.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$135.96 B 36,142.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$108.60 B 28,850.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland